Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	1001350-96-4
Formula :	C₂₃H₂₄FN₉O
M.W :	461.49
SMILES Code :	O=C([C@@]1(C)N(C(N=C2NC3=NNC(C4CC4)=C3)=NN5C2=CC=C5)CCC1)NC6=CC=C(F)N=C6
MDL No. :	MFCD18633202
InChI Key :	LQVXSNNAFNGRAH-QHCPKHFHSA-N
Pubchem ID :	24785538

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H319-H335
Precautionary Statements:	P261-P305+P351+P338

HCT116 cells	240 nM	48-72 hours	BMS-754807 treatment significantly induced p70S6K1 phosphorylation, indicating that IGF-1R inhibition activates p70S6K1 via MEK1/2 to promote cell survival	PMC7447751
SW480 cells	240 nM	48-72 hours	BMS-754807 treatment significantly induced p70S6K1 phosphorylation, indicating that IGF-1R inhibition activates p70S6K1 via MEK1/2 to promote cell survival	PMC7447751
MCF-7/AC-1 cells	10 μmol/L	24 hours	To evaluate the effect of BMS-754807 alone or in combination with hormonal therapies on the proliferation of MCF-7/AC-1 cells, results showed that BMS-754807 combined with 4-hydroxytamoxifen, letrozole, or fulvestrant had significant antiproliferative effects.	PMC4004036
HCT116 cells	240 nM	48 and 72 hours	Induced p70S6K1 phosphorylation, indicating activation of p70S6K1 through inhibition of IGF-1R signaling pathway	PMC7447751
SW480 cells	240 nM	48 and 72 hours	Induced p70S6K1 phosphorylation, indicating that this induction is independent of K-Ras or PIK3CA mutations	PMC7447751
HT29-P cells	240 nM	24 to 72 hours	Induced p70S6K1 phosphorylation, indicating that Pdcd4 knockdown enhanced BMS-754807-induced activation of p70S6K1, promoting cell survival	PMC7447751
HCT116 cells	240 nM	72 hours	Inhibition of p70S6K1 activation led to cell death, indicating that p70S6K1 phosphorylation is a key event for cell survival	PMC7447751
Pa01C	200 nM	72 hours	To evaluate the effect of BMS-754807 combined with CQ on PDAC cell proliferation, the results showed that the combination significantly increased cytotoxicity.	PMC8886214
Pa14C	200 nM	72 hours	To evaluate the effect of BMS-754807 combined with CQ on PDAC cell proliferation, the results showed that the combination significantly increased cytotoxicity.	PMC8886214
mT4	200 nM	72 hours	To evaluate the effect of BMS-754807 combined with CQ on PDAC cell proliferation, the results showed that the combination significantly increased cytotoxicity.	PMC8886214
breast cancer cell lines	0.1 μM to 25 μM	72 hours	To test the sensitivity of BMS-754807 in various breast cancer cell lines, results showed that triple-negative breast cancer cell lines were most sensitive to BMS-754807	PMC3073089
MIA-PaCa-2 cells	125 nM	72 hours	The combination of BMS-754807 and PD-0332991 significantly inhibited the proliferation of MIA-PaCa-2 cells, showing a synergistic effect.	PMC4122288
PSN1 cells	2.5-10 nM	2 hours and 16 hours	The combination of BMS-754807 and PD-0332991 significantly inhibited the phosphorylation of S6K1 in PSN1 cells, showing a synergistic effect.	PMC4122288
SMS-CTR	0 to 1000 nM	48 hours	To assess the impact of trametinib and ganitumab on apoptosis, results showed that trametinib alone or in combination with ganitumab increased the apoptosis rate in SMS-CTR cells.	PMC9852065
RD	0 to 1000 nM	48 hours	To assess the impact of trametinib and ganitumab on apoptosis, results showed that trametinib alone or in combination with ganitumab increased the apoptosis rate in RD cells.	PMC9852065

Nude mice	HCT116 cell xenograft model	Intraperitoneal injection	100 mg/kg	Once daily for 3 weeks	The combination of BMS-754807 and U0126 significantly suppressed tumor growth, indicating that inhibition of MEK1/2 overcomes IGF-1R inhibition-induced p70S6K1 activation to promote cell death	PMC7447751
nude mice	MCF-7/AC-1 xenograft model	oral	75 mg/kg	Twice daily, continued until the end of the experiment	To evaluate the antitumor activity of BMS-754807 alone or in combination with tamoxifen or letrozole in MCF-7/AC-1 xenografts, results showed that combination therapy significantly enhanced tumor regression without major side effects.	PMC4004036
Nude mice	HCT116 cell-derived tumor xenograft model	Intraperitoneal injection	50 mg/kg/d	once daily for 28 days	Combination of BMS-754807 and U0126 significantly suppressed tumor growth, indicating that inhibition of MEK1/2 abolishes BMS-754807-induced p70S6K1 phosphorylation and promotes cell death	PMC7447751
C57Bl/6 mice	mT4 cell xenograft model	Subcutaneous injection	25 mg/kg	Once daily for 12 days	To evaluate the effect of BMS-754807 combined with HCQ on tumor growth in the mT4 cell xenograft model, the results showed that the combination significantly reduced tumor burden.	PMC8886214
mice	triple-negative breast cancer tumorgraft model	oral	10 mg/kg	Once daily for 11 consecutive days	To test the efficacy of BMS-754807 alone or in combination with chemotherapy in a triple-negative breast cancer tumorgraft model, results showed that BMS-754807 significantly inhibited tumor growth, and combination with chemotherapy led to complete tumor regression	PMC3073089
Mice	YAPC cell xenograft model	Oral administration	12.5 mg/kg	Daily until tumors reached 15 mm	The combination of BMS-754807 and PD-0332991 significantly inhibited tumor growth in the YAPC cell xenograft model, showing a synergistic effect.	PMC4122288
SCID beige mice	RAS-mutated RMS xenograft models	oral gavage and intraperitoneal injection	50mg/kg	once daily for 14 days	To evaluate the tumor growth inhibitory effect of trametinib and ganitumab combination therapy, results showed that the combination significantly inhibited tumor growth and prolonged survival in the SMS-CTR model.	PMC9852065
Mice	Whole-body 12-Gy γ-irradiation injury model	Oral	BMS-754807 15 mg/kg, PD-0332991 75 mg/kg	Every other day for 21 days	To investigate the role of IGF-1 signaling inhibition in intestinal regeneration after radiation injury. Results showed that BMS-754807-treated mice exhibited more pronounced post-irradiation weight loss and impaired intestinal regeneration, characterized by blunted villi, reduced proliferation, and a 20% decrease in regenerating crypts.	PMC7502577

{[proInfo.proName]}

CAS No.: 1001350-96-4

{[proInfo.proName]}

CAS No.: 1001350-96-4

Alternative Products

Product Details of BMS-754807

Safety of BMS-754807

Related Pathways of BMS-754807

Isoform Comparison

Biological Activity

Protocol

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

NCT00898716	Neoplasms	PHASE1	COMPLETED	2025-07-11	Local Institution, Chuo-Ku, To... More >>kyo, 104-0045, Japan Less <<
NCT00569036	Neoplasms\|Solid Tumors\|Metasta... More >>ses Less <<	PHASE1	COMPLETED	2025-04-13	Local Institution, East Melbou... More >>rne, Victoria, 3002, Australia\|Local Institution, Footscray, Victoria, 3011, Australia\|Local Institution, Heidelberg, Victoria, 3084, Australia\|Local Institution, Parkville, Victoria, 3050, Australia\|Local Institution, Nedlands, Western Australia, 6009, Australia Less <<

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	2.17mL 0.43mL 0.22mL	10.83mL 2.17mL 1.08mL	21.67mL 4.33mL 2.17mL
Dissolving Methods	Animal experiment Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn: in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1 Protocol 2

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed